On November 30, in an application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, director of government and regulatory affairs at the SII, had sought an approval for

Covishield to be used for booster doses, citing an adequate stock of the vaccine in the country and a demand for booster shots due to the emergence of new coronavirus variants.